Price differences between generic and innovator medicines in Brazil;Diferenças de preços entre medicamentos genéricos e de referência no Brasil

Revista de Saude Publica

Volumn 40, Issue 3, 2006, Pages 444-449

  Viera, Fabiola Sulpino ^a   Zucchi, Paola ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Drug and narcotic control; Drug costs; Drug price; Drugs, generic, economics; Pharmaceuticals preparations, economics

Indexed keywords

GENERIC DRUG;

ARTICLE; BRAZIL; COMPARATIVE STUDY; DRUG COST; ECONOMIC ASPECT; ECONOMICS; HEALTH CARE POLICY; HUMAN;

BRAZIL; DRUG COSTS; DRUGS, GENERIC; ECONOMIC COMPETITION; HEALTH POLICY; HUMANS;

EID: 33847715499     PISSN: 00348910     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0034-89102006000300012     Document Type: Article

References (4)

1. Bermudez J. Medicamentos genéricos: uma alternativa para o mercado brasileiro. Cad Saúde Pública. 1994;10(3):368-78.
2. Ferrandiz JM. The impact of generic goods in the pharmaceutical industry. Health Econ. 1999;8(7):599-612.
3. King DR, Kanavos P. Encouraging the use of generic medicines: implications for transitions economies. Croat Med J. 2002;43(4):462-9.
4. Lexchin J. The effect of generic competition on the price of brand-name drugs. Health Policy. 2004;68(1):47-54.